AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Leigh Hopper
Feb. 16--Heart bypass patients and people at risk for colon cancer were at increased danger of heart attacks or strokes when treated with Vioxx, Celebrex and Bextra, according to three new studies published Tuesday, offering further evidence of problems posed by drugs known as COX-2 inhibitors.
The studies -- two from Houston and one from Harvard -- were released early by the New England Journal of Medicine for public health reasons and to coincide with a three-day Food and Drug Administration meeting.
At the meeting, which starts today, physicians and scientists will try to find a balance between benefits and risks of COX-2 drugs, which are taken by millions of people.
"I think we are at risk of losing the class of drugs," said Dr. Robert Bresalier, a University of Texas M.D. Anderson Cancer Center researcher who led a study on the use of Vioxx in preventing cancer. "That's why…